Health
CStone Announces Strategic Partnership and Exclusive Licensing Agreement with 3SBio for Nofazinlimab (Anti-PD-1 Antibody) in Mainland China
* CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in mainlandChina. CStone to retain the rights to nofazinlimab outside mainland China. * This partnership will combine the strengths of CStone a...
2023-11-01 18:10
2765
AXA BetterMe Weekend concludes in high note, drawing over 12,000 participants
Two-day carnival inspires physical and mental well-being Allowing citizens to unwind and rejuvenate to become a BetterMe HONG KONG, Nov. 1, 2023 /PRNewswire/ -- AXA BetterMe Weekend, the iconic annual carnival hosted by AXA Hong Kong andMacau (AXA) on 28 and 29 October 2023, was a resounding succ...
2023-11-01 18:02
1741
Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T
* Anbal-cel targeting DLBCL completes phase 2 trial * Anticipation growing over Korea's first CAR-T therapy ahead of regulatory review * Commercial manufacturing scheduled in 2025 at Korea's only CAR-T GMP facility DAEJEON, South Korea, Nov. 1, 2023 /PRNewswire/ -- Curocell, South Korea ...
2023-11-01 16:23
1234
Herbalife Survey Reveals More Than Half of Asia Pacific Consumers Find Support Groups Very Important in Their Health and Wellness Journeys
Herbalife Run returns this November to celebrate the power of community for supporting healthy, active living HONG KONG, Nov. 1, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released findings from itsAsia Pacific Power of Community Survey,revealing t...
2023-11-01 15:38
2314
P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns
* 1 in 2 Diabetics and 1 in 10 Pre-diabetics estimated to suffer from Peripheral Neuropathy * Vitamin B Deficiency affects quality of life of ~ 19% of all people with diabetes * #KnowtheSigns leverages Artificial Intelligence to make the invisible condition of Peripheral Neuropathy & Vitami...
2023-11-01 14:00
1683
New 'One World, One Health' Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health
JPA Health Unveils Connectability Score to Measure Relationships Between Key Audiences WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- A new report from JPA Health entitled, "One World, One Health: Exploring the Connectability between Human, Animal and Environmental Health," reveals a concerning lack o...
2023-11-01 12:01
1263
Extracellular Nanoparticles Sourced From Another Species Reverses Biological Age of Rats by More Than 50%
Peer Reviewed Publication: World's first demonstration of cross species epigenetic transfer that significantly reverses biological age by Scientists at Yuvan Research. MOUNTAIN VIEW, Calif., Nov. 1, 2023 /PRNewswire/ -- In a groundbreaking research paper titled"Reversal of Biological Age in Mult...
2023-11-01 09:14
994
Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata
LONDON, Nov. 1, 2023 /PRNewswire/ -- Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata. Final results of the study are anticipated to be ...
2023-11-01 09:05
896
Antengene Presents Results from Five Investigational Programs at 2023 SITC Annual Meeting
SHANGHAI and HONG KONG, Nov. 1, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer...
2023-11-01 08:30
1255
Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S.
WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, announced today at the American Society of Human Genetics (ASHG) Annual Meeting,Nov. 1-5, in Washington details on the commercial and technical momentum it has demonstrated in the last 10 months ...
2023-10-31 21:44
1401
88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the Latest Medical Technologies and Solutions
SHENZHEN, China, Oct. 31, 2023 /PRNewswire/ -- The 88th China International Medical Equipment Fair (CMEF) officially kicks off onOctober 28 at the Shenzhen World Exhibition & Convention Center. The four-day tradeshow will feature over 10,000 products brought by over 4,000 exhibitors from more tha...
2023-10-31 21:34
1711
BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures
NEW YORK, Oct. 31, 2023 /PRNewswire/ -- MSQ Ventures ("MSQ") is pleased to announce that its client, BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has entered into an exclusive license agreement with Guangzhou Gloria Biosciences Co., Ltd. (GloriaBio) and an associated investor for the deve...
2023-10-31 21:00
2864
Lunit Joins as an Associate Partner with the World Economic Forum
- Lunit joins as an Associate Partner of the World Economic Forum, propelling global expansion and collaboration in the realm of AI-driven cancer care SEOUL, South Korea, Oct. 31, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and th...
2023-10-31 21:00
1376
YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine
GAITHERSBURG, Md., Oct. 31, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...
2023-10-31 20:30
1228
Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City
YANGZHOU, China, Oct. 31, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today the establishme...
2023-10-31 20:00
2512
iba 2023: Angel Yeast brings latest baking products and solutions, empowering the China team to triumph in the iba.UIBC.Cup of Bakers
MUNICH, Oct. 31, 2023 /PRNewswire/ -- Premier global yeast company Angel Yeast
2023-10-31 20:00
2836
HOYA Vision Care Releases One-Year MiYOSMART European Study Results
Initial evidence-based findings of three-year study strongly supports MiYOSMART portfolio BANGKOK, Oct. 31, 2023 /PRNewswire/ -- HOYA Vision Care, committed to developing innovative solutions to address the growing problem of myopia progression in children, extended its research toEurope in an ...
2023-10-31 19:13
1430
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS
* FDA IND Clearance for CHM 2101, a novel 3rd generation CDH17 CAR T cell therapy * Anticipated to be the first CDH17 CAR T cell therapy to enter the clinic * Phase 1A clinical trial to initiate patient enrolment in 2024 * Phase 1A clinical trial will enroll patients with advanced Colorecta...
2023-10-31 19:00
1080
Select the Right Medical-Grade TPU：ICP DAS - BMP Launches a New TPU Series at COMPAMED & IPF Japan 2023
HSINCHU, Oct. 31, 2023 /PRNewswire/ -- ICP DAS – Biomedical Polymers, Asia's first medical-grade TPU (thermoplastic polyurethane) manufacturer and supplier, will be exhibiting at COMPAMED inGermany and IPF in Japan in November and December 2023. The company proudly presents its new Arothane™ ARP-...
2023-10-31 16:38
1630
Osteopathy Australia and Exercise & Sports Science Australia express profound disappointment in the tokenistic NDIS (National Disability Insurance Scheme) review process
SYDNEY, Oct. 31, 2023 /PRNewswire/ -- Osteopathy Australia, the peak body representing osteopathic healthcare professionals and Exercise & Sports Science Australia (ESSA), the peak professional organisation representing tertiary-trained exercise and sports science practitioners, today voiced thei...
2023-10-31 15:57
1298
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 318 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 310 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 296 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
15028
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
10441
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9816
